Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000386 · ClinicalTrials.gov registry record · Phase 3
Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)
A Phase 3 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00000386: Completed Phase 3 study, sponsored by National Institute of Mental Health (NIMH).
NCT00000386 is a Phase 3 study that has completed, run by National Institute of Mental Health (NIMH). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000386, a Phase 3 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to evaluate a behavioral treatment program for children and adolescents with OCD and their families. Exposure and Response Prevention (ERP) behavior therapy, in which the patient is gradually exposed to the object or situation that causes anxiety and is taught to refrain from responding in a compulsive manner, is combined with family counseling (Family Treatment Program). This treatment will be compared to Relaxation Training (RT). OCD is a long-term, often disabling disorder that can cause significant family disruption. ERP is a promising treatment for children with OCD, and it is thought that family participation (through the Family Treatment Program) may be a helpful addition. RT is a common treatment for anxiety. Patients are assigned randomly (like tossing a coin) to receive either the ERP/Family Treatment Program or RT. Both treatments will be delivered over 12 90-minute outpatient sessions to youngsters and their families. All participants (patients and family members) will be assessed for treatment response each month during treatment, after treatment is finished, and then at 2 follow-up visits over the following 6 months. A child/adolescent may be eligible for this study if he/she: Has obsessive-compulsive disorder (OCD), is medication-free, and is 8 to 17 years old.
Interventions
- BEHAVIORAL Exposure and Response Prevention
- BEHAVIORAL Behavior therapy
- BEHAVIORAL Relaxation Training
- BEHAVIORAL Family Treatment Program
- BEHAVIORAL Family Counseling
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-12 |
| Est. Completion | 2003-11 |
| Phase | Phase 3 |
What the finished NCT00000386 record still lists
NCT00000386 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which Exposure and Response Prevention is the first listed.
NCT00000386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000386 about?
NCT00000386 is a clinical study titled "Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)". The purpose of this study is to evaluate a behavioral treatment program for children and adolescents with OCD and their families. Exposure and Response Prevention (ERP) behavior therapy, in which the patient is gradually exposed to the object or situation that causes anxiety and is taught to refrain...
What is the current status of trial NCT00000386?
This trial is currently completed. It is a Phase 3 study. The study started on 1998-12. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00000386?
The interventions under investigation include: Exposure and Response Prevention (BEHAVIORAL), Behavior therapy (BEHAVIORAL), Relaxation Training (BEHAVIORAL), Family Treatment Program (BEHAVIORAL), Family Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000386?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia